Market Closed - Toronto S.E. 03:11:09 2024-04-30 pm EDT 5-day change 1st Jan Change
0.22 CAD -.--% Intraday chart for NexgenRx Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors CI
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024 CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023 CI
NexgenRx's Q1 Profit Falls, Revenue Rises MT
NexgenRx Inc. Appoints Dave Bennett as New Director CI
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NexgenRx Swings to Loss in Q4 MT
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022 CI
NexgenRx Announced Q2 2022 Financial Results MT
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022 CI
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending MT
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Nexgenrx Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
NexgenRx Inc. Announces Executive Changes CI
NexgenRx Inc. Reports Earnings Results for the First quarter Ended March 31, 2021 CI
Nexgenrx Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Update: NexgenRx Soars 31% as Reports Improvement in Third-Quarter Earnings MT
Chart NexgenRx Inc.
More charts
NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications in a of software-as-a-service model. The Company’s products include NexSys, NexAdmin, NexPension and NexPSPAssist. The NexSys product platform provides solution and simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. Its NexPension product is an advanced pension administration solution designed to help sponsors record and tabulate contributions for their membership group in a multi-employer environment. Its platform makes self-administration a reality.
More about the company
  1. Stock Market
  2. Equities
  3. NXG Stock
  4. News NexgenRx Inc.
  5. NexgenRx : Near 52 Week Lows as Reports Improvement in Third-Quarter Earnings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW